Trial Information

Summary: Drug Trial evaluating Seroquel versus Placebo for the Treatment of Patients with Bipolar Depression.

This is a 9 week study, 8 weeks receiving study medication, testing an investigational drug for the treatment of depression in Bipolar patients. At weekly, no-cost visits participants will have a 2/3 chance of receiving Seroquel and a 1/3 chance of receiving placebo. All necessary office visits, medical evaluations, and study medication will be provided at no cost to qualified patients.

Inclusion Criteria:

• Men and women between 18 and 65 with Bipolar Disorder.
• Outpatient status.
• Currently depressed.

Exclusion Criteria:

• Patients must not be suicidal.
• Rapid Cyclers.
• Treated with greater than 50mg of Seroquel in the last year.
• Any unstable medical condition.
• Pregnant or breastfeeding.

For more information,

If you would like to learn more about participating in this study, please send an e-mail message using the form below.